This clinical study is evaluating a new antibody treatment for Inflammatory Bowel Disease (IBD), a condition that causes abdominal pain and diarrhoea. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.
Be 18 to 55 years old
Be a healthy male or female